News
1d
Medical Device Network on MSNBD announces wearable injector trial for subcutaneous delivery of biologicsThe prefilled, patient-ready-to-use system is said to support delivery of high-viscosity biologics of up to 50 centipoise.
Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...
Pharmaceutical Technology serves as the connection to bio manufacturing and development, featuring regulatory updates and ...
BD has found a new home for its biosciences and diagnostics divisions at the lab equipment maker Waters Corporation, through ...
Becton Dickinson (BDX) announced the first pharma-sponsored combination product clinical trial using the BD Libertas Wearable Injector for ...
Waters and BD will merge biosciences and diagnostics in a $17.5B deal via Reverse Morris Trust, creating a life sciences ...
Franklin Lakes, New Jersey Thursday, July 24, 2025, 14:00 Hrs [IST] ...
The BD business will be spun off and merged with a Waters subsidiary. Waters shares were down about 11% in early trading ...
BD has picked a new executive to lead its planned connected care segment, as the company nears the conclusion of its ...
Plants in Cobb County and Covington have been the subject of lawsuits by cancer patients claiming the release of ethylene ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results